Lotus Pharmaceutical Co (美時化學製藥), which makes and distributes oral and injected medicine, yesterday said its future parent company Alvogen Inc spent US$187 million to acquire South Korean-based Dream Pharma Ltd, which is to be put under Lotus’ control once the deal is approved.
The US-based Alvogen, which makes generic drugs and biosimilars, plans to acquire the company through its South Koran subsidiary Kunwha Pharmaceutical Co, and the deal is still pending approval from the South Korean government, Lotus said.
Alvogen expects the deal to be completed in the fourth quarter of this year. The deal would make Kunwha the largest generic drug maker in South Korea, Lotus said.
The acquisition should strengthen Kunwha’s retail routes in South Korea and increase Kunwha’s product portfolio because the two companies sell different products, and Alvogen is set to sell its products to Taiwan and other markets in Asia using Alvogen’s networks, Lotus said.
“[The Asia-Pacific region] is one of the fastest-growing regions globally for generic pharmaceuticals. The market remains very fragmented, which provides an excellent opportunity for Alvogen to play a leading role in further industry consolidation,” Alvogen said in its statement yesterday.
Dream Pharma, a subsidiary of Hanwha Chemical Corp, which makes polyethylene, polyvinyl chloride plasticizer and base chemicals, reported revenue of about US$100 million last year, with 56 percent of that from sales of weight-loss drugs, Lotus said.
With 100 drugs currently in the pipeline, Dream Pharma accounts for 35 percent of the South Korean weight-loss drug market, according to Lotus.
“Dream Pharma is not a core business for Hanwha, and we believe we can increase its profit by adjusting Dream Pharma’s structure after acquiring it,” Lotus vice president Hung Yao-le (洪堯樂) said by telephone yesterday.
Alvogen is to spend US$200 million to acquire 67 percent of Lotus’ shares on Aug. 12, and Lotus also plans to spend US$180 million to seize 100 percent of South Korea-based Alvogen Korea and other Asian subsidiaries of Alvogen, Lotus said.
After Lotus acquired Alvogen Korea, Lotus would have a 67 percent stake in Kunwha, which posted a revenue of about US$80 million last year, Lotus said.
Both Dream Pharma and Kunwere in the black for last year, Hung said.
PATENTS: MediaTek Inc said it would not comment on ongoing legal cases, but does not expect the legal action by Huawei to affect its business operations Smartphone integrated chips designer MediaTek Inc (聯發科) on Friday said that a lawsuit filed by Chinese smartphone brand Huawei Technologies Co (華為) over alleged patent infringements would have little impact on its operations. In an announcement posted on the Taiwan Stock Exchange, MediaTek said that it would not comment on an ongoing legal case. However, the company said that Huawei’s legal action would have little impact on its operations. MediaTek’s statement came after China-based PRIP Research said on Thursday that Huawei filed a lawsuit with a Chinese district court claiming that MediaTek infringed on its patents. The infringement mentioned in the lawsuit likely involved
Taipei is today suspending work, classes and its US$2.4 trillion stock market as Typhoon Gaemi approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed income trading, statements from its stock and currency exchanges said. Authorities had yesterday issued a warning that the storm could affect people on land and canceled some ship crossings and domestic flights. Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) expects its local chipmaking fabs to maintain normal production, the company said in an e-mailed statement. The main chipmaker for Apple Inc and Nvidia Corp said it has activated routine typhoon alert
GROWTH: TSMC increased its projected revenue growth for this year to more than 25 percent, citing stronger-than-expected demand for AI devices and smartphones The Taiwan Institute of Economic Research (TIER, 台灣經濟研究院) yesterday raised its forecast for Taiwan’s GDP growth this year from 3.29 percent to 3.85 percent, as exports and private investment recovered faster than it predicted three months ago. The Taipei-based think tank also expects that Taiwan would see a 8.19 percent increase in exports this year, better than the 7.55 percent it projected in April, as US technology giants spent more money on artificial intelligence (AI) infrastructure and development. “There will be more AI servers going forward, but it remains to be seen if the momentum would extend to personal computers, smartphones and
Catastrophic computer outages caused by a software update from one company have once again exposed the dangers of global technological dependence on a handful of players, experts said on Friday. A flawed update sent out by the little-known security firm CrowdStrike Holdings Inc brought airlines, TV stations and myriad other aspects of daily life to a standstill. The outages affected companies or individuals that use CrowdStrike on the Microsoft Inc’s Windows platform. When they applied the update, the incompatible software crashed computers into a frozen state known as the “blue screen of death.” “Today CrowdStrike has become a household name, but not in